lantus 100 u ml 100 unităţi/ml soluţie injectabilă în flacon
sanofi-aventis deutschland gmbh - insulinum glarginum - soluţie injectabilă în flacon - 100 unităţi/ml
glaritus 100 ui/ml soluție injectabilă în cartuș
wockhardt limited - insulinum glarginum - soluție injectabilă în cartuș - 100 ui/ml
glaritus dispopen 100 ui/ml soluţie injectabilă în stilou injector (pen) preumplut
wockhardt limited - insulinum glarginum - soluţie injectabilă în stilou injector (pen) preumplut - 100 ui/ml
insulin aspart sanofi
sanofi winthrop industrie - insulina aspart - diabetul zaharat - medicamente utilizate în diabet - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
abiraterone accord
accord healthcare s.l.u. - acetat de abirateron - prostate neoplasme - terapia endocrină - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterona zentiva 250 mg
synthon hispania s.l. - spania - abirateronum - compr. - 250mg - antagonisti hormonali si substante inrudite alti antagonisti hormonali si substante inrudite
abiraterona zentiva 500 mg
synthon hispania s.l. - spania - abirateronum - compr. film. - 500mg - antagonisti hormonali si substante inrudite alti antagonisti hormonali si substante inrudite
abiraterone mylan
mylan ireland limited - acetat de abirateron - prostate neoplasme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterona dr. reddy's 500 mg
synthon hispania, s.l. - spania - abirateronum - compr. film. - 500mg - antagonisti hormonali si substante inrudite alti antagonisti hormonali si substante inrudite
abiraterona lannacher 250 mg
synthon hispania, s.l. - spania - abirateronum - compr. - 250mg - antagonisti hormonali si substante inrudite alti antagonisti hormonali si substante inrudite